-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Long-Term Outcomes Following Postoperative SRS vs WBRT for Resected Brain Metastasis - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 05 Tips for Staying Updated in Medical Literature - 2 year(s) ago
Interview with Michael J. Grant MD
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Written by Azael Freites-Martinez MD
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Iberdomide Plus Dexamethasone for Heavily Pretreated Late-Line Relapsed/Refractory Multiple Myeloma - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Cancer - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Robot-Assisted Partial Nephrectomy vs Percutaneous Thermal Ablation in Patients With a Solitary Kidney With RCC cT1 - 2 year(s) ago
Read it now on PracticeUpdate.com
Source: PracticeUpdateCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Treatment Characteristics and Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy https://t.co/Ko4ZUHg6QX #lcsm #lungcancer